Wyeth Holdings Corp. v. Sebelius, 603 F.3d 1291, CPLRG 0061(Fed. Cir. 2010) (MOORE, Bryson & Folsom, district judge) Wyeth05032010

MAJOR ISSUES:  patent term extension; Food and Drug Administration (FDA) regulatory review period; animal drugs; deference to administrative agency interpretation of statute Read CPLRG™ 0061

Bradford Co. v. ConTeyor North America, Inc., 603 F.3d 1262, CPLRG 0060 (Fed. Cir. 2010) (LOURIE, Clevenger & Rader)Bradford04292010

MAJOR ISSUES:  estoppel against claim to priority of earlier-filed application; opposition to PTO double patenting rejection; argument distinguishing later application from earlier application; personal jurisdiction; Belgian corporation’s contact with the United States as a whole; Rule 4(k)(2); claim interpretation; claim differentiation Read CPLRG™ 0060

Avid Identification Systems, Inc. v. Crystal Import Corp., 603 F.3d 967, CPLRG 0059 (Fed. Cir. 2010) (PROST & Mayer; LINN, concurring-in-part & dissenting-in-part)AvidIdentification04272010

MAJOR ISSUES:  inequitable conduct; individuals subject to duty of candor; person other than inventors, attorneys and agents; substantive involvement in preparation or prosecution of patent application Read CPLRG™ 0059

Alza Corp. v. Andrx Pharmaceuticals, LLC, 693 F.3d 935, CPLRG 0057 (Fed. Cir. 2010) (PROST, Dyk & Schall) AlzaAndrx04262010

MAJOR ISSUES: enablement; full scope of claim; claim broadly construed to show infringement not enabled; undue experimentation Read CPLRG™ 0057

Therasense, Inc. v. Becton, Dickinson & Co., 374 Fed. Appx. 35, CPLRG 0058 (Fed. Cir. 2010) (En Banc). TherasenseEnBancOrder

MAJOR ISSUES: inequitable conduct; unenforceability of patents; fraud. Read CPLRG™ 0058